Derlin-1 and p97/valosin-containing protein mediate the endoplasmic reticulum-associated degradation of human V2 vasopressin receptors

Molecular Pharmacology

Volumn 73, Issue 3, 2008, Pages 697-708

  Schwieger, Isabel ^a   Lautz, Katja ^a   Krause, Eberhard ^a   Rosenthal, Walter ^a   Wiesner, Burkhard ^a   Hermosilla, Ricardo ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DERLIN 1 PROTEIN; PROTEIN; PROTEIN P97; UNCLASSIFIED DRUG; VALOSIN CONTAINING PROTEIN; VASOPRESSIN V2 RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CELL STRAIN HEK293; DEGRADATION; ENDOPLASMIC RETICULUM; GLYCOSYLATION AND DEGLYCOSYLATION; HUMAN; HUMAN CELL; NEPHROGENIC DIABETES INSIPIDUS; PRIORITY JOURNAL; X CHROMOSOME LINKAGE;

ADENOSINE TRIPHOSPHATASES; ADENYLATE CYCLASE; AMINO ACID SEQUENCE; ARGININE VASOPRESSIN; CELL CYCLE PROTEINS; CELL LINE; CHLOROQUINE; ENDOPLASMIC RETICULUM; GREEN FLUORESCENT PROTEINS; HUMANS; KIDNEY; LYSOSOMES; MEMBRANE PROTEINS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PLASMIDS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, VASOPRESSIN; SUBCELLULAR FRACTIONS; TRANSFECTION; UBIQUITINATION;

EID: 40849147267     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.040931     Document Type: Article

References (38)

1. Aridor M and Hannan LA (2000) Traffic jam: a compendium of human diseases that affect intracellular transport processes. Traffic 1:836-851.
2. Aridor M and Hannan LA (2002) Traffic jams II: an update of diseases of intracellular transport. Traffic 3:781-790.
3. Babbitt SE, Kiss A, Deffenbaugh AE, Chang YH, Bailly E, Erdjument-Bromage H, Tempst P, Buranda T, Sklar LA, Baumler J, et al. (2005) ATP hydrolysis-dependent disassembly of the 26S proteasome is part of the catalytic cycle. Cell 121:553-565.
4. Bernier V, Morello JP, Zarruk A, Debrand N, Salahpour A, Lonergan M, Arthus MF, Laperrière A, Brouard R, Bouvier M, et al. (2006) Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol 17:232-243.
5. Bouley R, Lin HY, Raychowdhury MK, Marshansky V, Brown D, and Ausiello DA (2005) Downregulation of the vasopressin type 2 receptor after vasopressin-induced internalization: involvement of a lysosomal degradation pathway. Am J Physiol Cell Physiol 288:C1390-C1401.
6. Brodsky JL and McCracken AA (1999) ER protein quality control and proteasome-mediated protein degradation. Semin Cell Dev Biol 10:507-513.
7. Carvalho P, Goder V, and Rapoport TA (2006) Distinct ubiquitin-ligase complexes define convergent pathways for the degradation of ER proteins. Cell 126:361-373.
8. Ciechanover A (2006) Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting. Exp Biol Med (Maywood) 231:1197-1211.
9. Czupalla C, Mansukoski H, Riedl T, Thiel D, Krause E, and Hoflack B (2006) Proteomic analysis of lysosomal acid hydrolases secreted by osteoclasts: implications for lytic enzyme transport and bone metabolism. Mol Cell Proteomics 5:134-143.
10. Gazit G, Lu J, and Lee AS (1999) De-regulation of GRP stress protein expression in human breast cancer cell lines. Breast Cancer Res Treat 54:135-146.
11. Hampton RY (2002) ER-associated degradation in protein quality control and cellular regulation. Curr Opin Cell Biol 14:476-482.
12. Hermosilla R, Oueslati M, Donalies U, Schönenberger E, Krause E, Oksche A, Rosenthal W, and Schülein R (2004) Disease-causing V(2) vasopressin receptors are retained in different compartments of the early secretory pathway. Traffic 5:993-1005.
13. Kalies KU, Allan S, Sergeyenko T, Kroger H, and Romisch K (2005) The protein translocation channel binds proteasomes to the endoplasmic reticulum membrane. EMBO J 24:2284-2293.
14. Kopito RR (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol 10:524-530.
15. Krause G, Hermosilla R, Oksche A, Rutz C, Rosenthal W, and Schülein R (2000) Molecular and conformational features of a transport-relevant domain in the C-terminal tail of the vasopressin V2 receptor. Mol Pharmacol 57:232-242.
16. Kyhse-Andersen J (1984) Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J Biochem Biophys Methods 10:203-209.
17. Martin NP, Lefkowitz RJ, and Shenoy SK (2003) Regulation of V2 vasopressin receptor degradation by agonist-promoted ubiquitination. J Biol Chem 278:45954-45959.
18. Meusser B, Hirsch C, Jarosch E, and Sommer T (2005) ERAD: the long road to destruction. Nat Cell Biol 7:766-772.
19. Ng W, Sergeyenko T, Zeng N, Brown JD, and Romisch K (2007) Characterization of the proteasome interaction with the Sec61 channel in the endoplasmic reticulum. J Cell Sci 120:682-691.
20. Oksche A, Dehe M, Schülein R, Wiesner B, and Rosenthal W (1998) Folding and cell surface expression of the vasopressin V2 receptor: requirement of the intracellular C-terminus. FEBS Lett 424:57-62.
21. Petäjä-Repo UE, Hogue M, Laperrière A, Bhalla S, Walker P, and Bouvier M (2001) Newly synthesized human δ opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome. J Biol Chem 276:4416-4423.
22. Pietilä EM, Tuusa JT, Apaja PM, Aatsinki JT, Hakalahti AE, Rajaniemi HJ, and Petäjä-Repo UE (2005) Inefficient maturation of the rat luteinizing hormone receptor: a putative way to regulate receptor numbers at the cell surface. J Biol Chem 280:26622-26629.
23. Robben JH, Knoers NV, and Deen PM (2004) Regulation of the vasopressin V2 receptor by vasopressin in polarized renal collecting duct cells. Mol Biol Cell 15:5693-5699.
24. Robben JH, Knoers NV, and Deen PM (2005) Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model. Am J Physiol Renal Physiol 289:F265-F272.
25. Robben JH, Knoers NV, and Deen PM (2006) Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus. Am J Physiol Renal Physiol 291:F257-F270.
26. Sambrook J and Russell DW (2001) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
27. Schülein R, Hermosilla R, Oksche A, Dehe M, Wiesner B, Krause G, and Rosenthal W (1998) A dileucine sequence and an upstream glutamate residue in the intracellular carboxyl terminus of the vasopressin V2 receptor are essential for cell surface transport in COS.M6 cells. Mol Pharmacol 54:525-535.
28. Schülein R, Liebenhoff U, Müller H, Birnbaumer M, and Rosenthal W (1996) Properties of the human arginine vasopressin V2 receptor after site-directed mutagenesis of its putative palmitoylation site. Biochem J 313:611-616.
29. Sun F, Zhang R, Gong X, Geng X, Drain PF, and Frizzell RA (2006) Derlin-1 promotes the efficient degradation of the cystic fibrosis transmembrane conductance regulator (CFTR) and CFTR folding mutants. J Biol Chem 281:36856-36863.
30. Vij N, Fang S, and Zeitlin PL (2006) Selective inhibition of endoplasmic reticulum-associated degradation rescues ΔF508-cystic fibrosis transmembrane regulator and suppresses interleukin-8 levels: therapeutic implications. J Biol Chem 281:17369-17378.
31. Wahlman J, Demartino GN, Skach WR, Bulleid NJ, Brodsky JL, and Johnson AE (2007) Real-time fluorescence detection of ERAD substrate retrotranslocation in a mammalian in vitro system. Cell 129:943-955.
32. Wang Q, Song C, and Li CC (2004) Molecular perspectives on p97-VCP: progress in understanding its structure and diverse biological functions. J Struct Biol 146:44-57.
33. Werner ED, Brodsky JL, and McCracken AA (1996) Proteasome-dependent endoplasmic reticulum-associated protein degradation: An unconventional route to a familiar fate. Proc Natl Acad Sci U S A 93:13797-13801.
34. Wüller S, Wiesner B, Löffler A, Furkert J, Krause G, Hermosilla R, Schaefer M, Schülein R, Rosenthal W, and Oksche A (2004) Pharmacochaperones post-translationally enhance cell surface expression by increasing conformational stability of wild-type and mutant vasopressin V2 receptors. J Biol Chem 279:47254-47263.
35. Ye Y (2006) Diverse functions with a common regulator: ubiquitin takes command of an AAA ATPase. J Struct Biol 156:29-40.
36. Ye Y, Shibata Y, Kikkert M, van Voorden S, Wiertz E, and Rapoport TA (2005) Inaugural Article: Recruitment of the p97 ATPase and ubiquitin ligases to the site of retrotranslocation at the endoplasmic reticulum membrane. Proc Natl Acad Sci U S A 102:14132-14138.
37. Ye Y, Shibata Y, Yun C, Ron D, and Rapoport TA (2004) A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 429:841-847.
38. Zhang K and Kaufman RJ (2006) The unfolded protein response: a stress signaling pathway critical for health and disease. Neurology 66:S102-S109.